<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT944-7396</title>
	</head>
	<body>
		<main>
			<p>941124 FT  24 NOV 94 / London Stock Exchange: SmithKline bounces Pharmaceuticals group SmithKline Beecham recovered strongly as the company announced a Pounds 920m (Dollars 1.45bn) disposal. The shares, down 12 at one stage, ended a net 2 off at 421p, while the Units, which tend to reflect US interest, finished marginally lower at 385p. SmithKline is selling its global animal health business to Pfizer and, although the move had been anticipated, it was only expected to realise one to 1.5 times annual sales. In fact, it went for 2 1/2 times sales and is expected to reduce the net debt to around Dollars 1.7bn. Mr Paul Krikler of Goldman Sachs applauded the deal, saying: 'This clearly demonstrates that management has kept to its promise to reduce debt through disposals. In addition, the price looks very good.'</p>
		</main>
</body></html>
            